{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:49:10Z","timestamp":1794077350998,"version":"4.8.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0057174"],"award-info":[{"award-number":["NNF19OC0057174"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008550","name":"Diabetesfonden","doi-asserted-by":"publisher","award":["DIA 2018-384"],"award-info":[{"award-number":["DIA 2018-384"]}],"id":[{"id":"10.13039\/501100008550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN2017\/472"],"award-info":[{"award-number":["CAN2017\/472"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatoma cell lines are widely used to model the hepatocyte for insulin signaling and fatty liver disease. However, a direct comparison of insulin action in primary hepatocytes and in hepatoma cell lines is needed to validate this model and to better understand liver cancer. Here we have investigated insulin signaling, gluconeogenic gene expression, glucose production, and fatty acid synthase abundance in primary hepatocytes and in HepG2, Hepa 1\u20136, and McARH7777 hepatoma cell lines. Differences in the electrophoretic profiles of protein extracts from human and mouse primary hepatocytes and the hepatoma cells lines are shown. Compared to primary hepatocytes, hepatoma cells showed high basal phosphorylation of AKT at Thr 308 and constitutively activated RAS-MAPK signaling, which were resistant to the dominant negative Ras mutant H-Ras17N. Hepatoma cell lines also showed defective expression of gluconeogenic enzymes, insulin unresponsive GSK phosphorylation, and marginal glucose production. Hepatoma cells also showed lower protein levels of fatty acid synthase and a largely distinct protein electrophoresis profile from hepatocytes but similar between different hepatoma lines. We conclude that hepatoma cell lines do not accurately model the hepatocyte for insulin action but may be valuable tools to investigate the proteomic changes conferring to hepatocellular carcinoma its peculiar metabolisms.<\/jats:p>","DOI":"10.1038\/s41598-020-68721-9","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T10:02:52Z","timestamp":1595325772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype"],"prefix":"10.1038","volume":"10","author":[{"given":"Angela","family":"Molinaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Becattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Solinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"68721_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40842-016-0039-3","volume":"3","author":"PZ Zimmet","year":"2017","unstructured":"Zimmet, P. Z. Diabetes and its drivers: the largest epidemic in human history?. Clin. Diabetes Endocrinol. 3, 1. https:\/\/doi.org\/10.1186\/s40842-016-0039-3 (2017).","journal-title":"Clin. Diabetes Endocrinol."},{"key":"68721_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes, C. et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J. Hepatol. 69, 896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036 (2018).","journal-title":"J. Hepatol."},{"key":"68721_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel, V. T. & Shulman, G. I. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 27, 22\u201341. https:\/\/doi.org\/10.1016\/j.cmet.2017.08.002 (2018).","journal-title":"Cell Metab."},{"key":"68721_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","volume":"28","author":"PM Titchenell","year":"2017","unstructured":"Titchenell, P. M., Lazar, M. A. & Birnbaum, M. J. Unraveling the regulation of hepatic metabolism by insulin. Trends Endocrinol. Metab. 28, 497\u2013505. https:\/\/doi.org\/10.1016\/j.tem.2017.03.003 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"68721_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molmet.2015.03.004","volume":"4","author":"G Solinas","year":"2015","unstructured":"Solinas, G., Boren, J. & De Dulloo, A. G. novo lipogenesis in metabolic homeostasis: more friend than foe?. Mol. Metab. 4, 367\u2013377. https:\/\/doi.org\/10.1016\/j.molmet.2015.03.004 (2015).","journal-title":"Mol. Metab."},{"key":"68721_CR6","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017 (2018).","journal-title":"Physiol. Rev."},{"key":"68721_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.03.010","author":"A Molinaro","year":"2019","unstructured":"Molinaro, A. et al. Insulin-driven PI3K-AKT signaling in the hepatocyte is mediated by redundant PI3Kalpha and PI3Kbeta activities and is promoted by RAS. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2019.03.010 (2019).","journal-title":"Cell Metab."},{"key":"68721_CR8","doi-asserted-by":"publisher","first-page":"e91863","DOI":"10.1172\/jci.insight.91863","volume":"2","author":"DS Edgerton","year":"2017","unstructured":"Edgerton, D. S. et al. Insulin\u2019s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion. JCI Insight 2, e91863. https:\/\/doi.org\/10.1172\/jci.insight.91863 (2017).","journal-title":"JCI Insight"},{"key":"68721_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.26414","volume":"58","author":"C Rowe","year":"2013","unstructured":"Rowe, C. et al. Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation. Hepatology 58, 799\u2013809. https:\/\/doi.org\/10.1002\/hep.26414 (2013).","journal-title":"Hepatology"},{"key":"68721_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","volume":"136","author":"JR Wisniewski","year":"2016","unstructured":"Wisniewski, J. R., Vildhede, A., Noren, A. & Artursson, P. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. J. Proteom. 136, 234\u2013247. https:\/\/doi.org\/10.1016\/j.jprot.2016.01.016 (2016).","journal-title":"J. Proteom."},{"key":"68721_CR11","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1152\/ajpendo.00365.2018","volume":"316","author":"SR Nagarajan","year":"2019","unstructured":"Nagarajan, S. R. et al. Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism. Am. J. Physiol. Endocrinol. Metab. 316, E578\u2013E589. https:\/\/doi.org\/10.1152\/ajpendo.00365.2018 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"68721_CR12","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.180147","author":"S Sefried","year":"2018","unstructured":"Sefried, S., Haring, H. U., Weigert, C. & Eckstein, S. S. Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression. Open Biol. https:\/\/doi.org\/10.1098\/rsob.180147 (2018).","journal-title":"Open Biol."},{"key":"68721_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-8-S2-S5","author":"B Chen","year":"2015","unstructured":"Chen, B., Sirota, M., Fan-Minogue, H., Hadley, D. & Butte, A. J. Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research. BMC Med. Genom. https:\/\/doi.org\/10.1186\/1755-8794-8-S2-S5 (2015).","journal-title":"BMC Med. Genom."},{"key":"68721_CR14","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1038\/ncomms3508","volume":"4","author":"R Ma","year":"2013","unstructured":"Ma, R. et al. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat. Commun. 4, 2508. https:\/\/doi.org\/10.1038\/ncomms3508 (2013).","journal-title":"Nat. Commun."},{"key":"68721_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","volume":"140","author":"DF Calvisi","year":"2011","unstructured":"Calvisi, D. F. et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140, 1071\u20131083. https:\/\/doi.org\/10.1053\/j.gastro.2010.12.006 (2011).","journal-title":"Gastroenterology"},{"key":"68721_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2337\/db12-0255","volume":"62","author":"H Marcelino","year":"2013","unstructured":"Marcelino, H. et al. A role for adipose tissue de novo lipogenesis in glucose homeostasis during catch-up growth: a Randle cycle favoring fat storage. Diabetes 62, 362\u2013372 (2013).","journal-title":"Diabetes"},{"key":"68721_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1172\/JCI97712","volume":"129","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT\/mTOR signaling. J. Clin. Investig. 129, 1015\u20131029. https:\/\/doi.org\/10.1172\/JCI97712 (2019).","journal-title":"J. Clin. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68721-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:03:44Z","timestamp":1670335424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68721-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68721"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68721-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"17 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12031"}}